Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 8/20 | 0.42 |
| ▸ | LGALS7; LGALS7B | P47929 | 4/20 | 0.42 |
| ▸ | LGALS9 | O00182 | 4/20 | 0.42 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.32 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24635181 | 0.95 | LGALS3 (0.42) | LGALS3LGALS7; LGALS7BLGALS9LGALS1POLB | |
| SCHEMBL25970268 | 0.89 | LGALS3 (0.38) | LGALS3LGALS7; LGALS7BLGALS9LGALS1POLB | |
| SCHEMBL25963114 | 0.89 | LGALS3 (0.38) | LGALS3LGALS7; LGALS7BLGALS9LGALS1POLB | |
| SCHEMBL24478860 | 0.89 | LGALS3 (0.38) | LGALS3LGALS7; LGALS7BLGALS9LGALS1POLB | |
| SCHEMBL24478872 | 0.87 | LGALS3 (0.38) | LGALS3LGALS7; LGALS7BLGALS9LGALS1POLB | |
| SCHEMBL24478861 | 0.82 | LGALS3 (0.38) | LGALS3LGALS7; LGALS7BLGALS9LGALS1LGALS8 | |
| SCHEMBL24635649 | 0.80 | LGALS3 (0.38) | LGALS3LGALS7; LGALS7BLGALS9LGALS1POLB | |
| SCHEMBL23322296 | 0.78 | LGALS3 (0.37) | LGALS3LGALS7; LGALS7BLGALS9LGALS1CA12 | |
| SCHEMBL23280950 | 0.73 | LGALS8 (0.48) | LGALS3LGALS7; LGALS7BLGALS9LGALS1LGALS8 | |
| SCHEMBL23322857 | 0.73 | LMNA (0.34) | CA12CA1CA2CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230256109-A1 | Trans-Cyclooctene Bioorthogonal Agents and Uses in Cancer and Immunotherapy | TAMBO, INC. | 2023-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230256109-A1 | Trans-Cyclooctene Bioorthogonal Agents and Uses in Cancer and Immunotherapy | ICOS, CD74, PBK | LGALS3 160/4885LGALS7; LGALS7B 176/4885LGALS9 248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.